VANCOUVER, BC – Life Sciences British Columbia (LSBC) is proud to present the 10th Annual Invest in BC, powered by Lumira Ventures, taking place October 28–29, 2025 at the Vancouver… Read More
The BC Centre for Excellence in HIV/AIDS (BC-CfE) is pleased to congratulate BC-CfE Laboratory Director Dr. Zabrina Brumme on her appointment as a Fellow of the Canadian Academy of Health… Read More
Ozempic® is the first-and-only medication indicated for both the once-weekly treatment of adult patients with type 2 diabetes mellitus to improve glycemic control and to reduce the risk of sustained… Read More
Acquisition adds a potential first-in-class in vivo targeted lipid nanoparticle (tLNP) anti-CD19 CAR-T therapy candidate for B cell-mediated autoimmune diseases as well as a proprietary tLNP platform designed to deliver RNA… Read More
VANCOUVER, BC – Acuitas Therapeutics announced the publication of a new study in Science Translational Medicine, titled “Nonstabilized SARS-CoV-2 spike mRNA vaccination induces broadly neutralizing antibodies in nonhuman primates.” The… Read More
